Manipulating Milestones in Pandemic Times with AGTC’s Sue Washer
The COVID-19 pandemic continues to disrupt biopharma clinical trials, especially those conducted with at-risk patient populations. From patient recruitment to data collection, clinical trials execution became considerably more challenging in 2020. On this episode of The Business Of Biotech, UF startup and UF Innovate | Sid Martin Biotech graduate AGTC CEO Sue Washer gives us a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones.
Two Cise Professors Named 2021 IEEE Fellows
The IEEE has named two professors from the Department of Computer & Information Science & Engineering (CISE) as 2021 Fellows. Professors Prabhat Mishra,... Read More
Two UF Professors Elected to National Academy of Inventors
Two members of the UF community were named as Fellows of the National Academy of Inventors (NAI), the highest professional distinction accorded... Read More
Pandemic a Boon for Area’s Biotech Industry
While industries like airlines, hospitality and retail struggled much of 2020, one local sector took off during the COVID-19 pandemic. Alachua’s biotechnology... Read More
Technological Advances Help Better Regulate the Growing Cannabis Market
Since sixteen states have now fully legalized the use of cannabis products for both medical and recreational use, a major concern over... Read More
The Hub’s Century 22 Solutions Announces New Board of Advisors Member
UF Innovate | The Hub resident client Century 22 Solutions LLC, a technology services and solutions company that provides integration, UAV, R&D,... Read More
AI: The Future of Farming is Happening Today
What was once the future of farming is happening today at the University of Florida/IFAS. Scott Angle, Vice President for Agriculture and... Read More
GrowFL Features Admiral in Florida Companies to Watch
UF Innovate | The Hub startup Admiral is a 2020 GrowFL Florida Companies to Watch honoree. In Inside GrowFL’s December edition, you’ll... Read More
Algernon Pharmaceuticals Lead Drug Ifenprodil Named As Potential COVID-19 Treatment in European Scientific Journal
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, said that its lead drug candidate Ifenprodil was highlighted in a European... Read More
UF Startup Shadow Health Is Going Big and Staying Home
In early December, local UF startup Shadow Health, which develops virtual simulations for nursing and healthcare education, became part of Elsevier, a global leader in information and analytics, that is part of RELX, an even larger global provider of information-based analytics. The acquisition will hasten Shadow Health’s ability to reach its biggest goals.
